menu
search
date_range
expand_more
1 Year
login
Sign In
home
Home
explore
Dashboard
bookmark_border
Bookmarks
show_chart
Portfolios
search
Explorer
arrow_drop_down
Funds
Equities
library_books
Library
rss_feed
Insights
link
Pinindices
smartphone
Mobile
arrow_drop_down
App Store
Android
Dashboard
chevron_right
Biotechnology
Global Health Care ETFs
Dedicated funds with distinct performance / volatility profiles and investment options
trending_up
38.6%
list
16
Next 60 MidCap Biotech Firms
With market capitalizations between $2bn and $10bn, the performance of the midcap biotech selection has gained momentum
trending_up
118.3%
list
61
Biotechnology - Top 100 by Market Cap
Targeted access to a large selection of biotechnology and pharmaceutical stocks (large-, mid- and small-cap)
trending_up
102.4%
list
100
US NASDAQ 100 ETFs
A selection of ETFs seeking to track NASDAQ indices and factors, with a range of filters and of option overlays
trending_up
25.8%
list
10
China Biotech - Rising Stars ?
Concentrating minds on breakthrough medication - Chinese biotech with a mission
trending_up
21.8%
list
11
article
2
Biotechnology Breakthroughs ETFs
Diversified selections or focused investment models in Biotech R&D
trending_up
62.0%
list
10
Healthcare Innovation ETFs
Deeply transformative healthcare expectations or ever hopeful promises of basic research advance
trending_up
37.2%
list
9
Next 60 Small-Cap Biotech
Selection of small market cap biotech firms, below $2 billion
trending_up
83.4%
list
60
30 Biotech LargeCap Firms
The biotech firms, with market capitalization exceeding $10 billion, are strong contributors to the industry's performance - Momentum is indicative of the sector's resilience
trending_up
62.5%
list
30
